1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
ResMed said its chief commercial officer for the residential care software business, Bobby Ghoshal, notified the company on July 28, 2025 that he intends to resign effective August 1, 2025, to become chief operating officer of a software company outside its industry. The filing does not name a successor or describe any financial impact.
Bobby Ghoshal, chief commercial officer of the residential care software business (RCS), gave notice on July 28, 2025.
Resignation is effective August 1, 2025.
He plans to join a software company in a non-competitive industry as chief operating officer.
The filing does not name a replacement or report any financial effect.
Core Natural Resources and subsidiaries entered into a Receivables Financing Agreement dated July 28, 2025, with PNC Bank as administrative agent, supporting letters of credit and a borrowing capacity of $250 million, maturing July 27, 2028. The agreement replaces the existing receivables purchase arrangements dated October 5, 2016, and the company voluntarily repaid a prior 2017 receivables facility. The filing describes new fees and a guarantee by Core, which add to the company's direct financial obligations.
Borrowing capacity and letter of credit support of $250 million, maturing July 27, 2028
Loans accrue interest at term SOFR plus 10 basis points; letters of credit carry a 2.00% per annum participation fee
Prior CONSOL Funding receivables facility from November 30, 2017 was voluntarily repaid and its letters of credit transferred
Core guarantees the arrangement in favor of PNC Bank under a Fifth Amended and Restated Performance Guaranty
The filing names ASGN Incorporated, not Everforth Inc, so this summary covers ASGN. On July 31, 2025, ASGN signed a second amendment to its credit agreement and borrowed the full $100.0 million incremental Term A loan. The loan matures February 14, 2028, is secured by substantially all of the company's assets, and adds secured debt that must be repaid on a set amortization schedule.
Incremental Term A loan of $100.0 million, borrowed in full on July 31, 2025
Maturity date February 14, 2028; quarterly amortization of $625,000 for the first four fiscal quarters after the effective date, then $1,250,000 per quarter
Company must keep a consolidated secured leverage ratio of not greater than 3.75 to 1.00
Proceeds may fund organic investments, add availability under the $500 million revolving credit facility for acquisitions, and support share buybacks
Shenandoah Telecommunications' board named Edward H. McKay, its current Executive Vice President and Chief Operating Officer, as President and Chief Executive Officer, effective September 1, 2025. Christopher E. French, the current CEO, becomes Executive Chairman on the same date and remains an officer as well as Chairman, and the board adopted amended bylaws to create the Executive Chairman role. For shareholders, this is a planned leadership succession, with the filing stating that it is intended to ensure continuity of strategy.
Edward H. McKay, 52, becomes President and CEO effective September 1, 2025; he has been COO since July 2021 and joined Shentel in 2004
Christopher E. French moves from President and CEO to Executive Chairman effective September 1, 2025
McKay's annual base salary will be $550,000 with a 90% target bonus; French's will be $450,000 with an 80% target bonus
CenterPoint Energy completed a private sale of $1.0 billion in 3.00% convertible senior notes due August 1, 2028, including a $100 million option exercised by the initial purchasers. Net proceeds were about $986.8 million, and the notes can convert into cash and common stock at an initial price of about $46.63 per share. The deal adds $1.0 billion of debt, with potential future share dilution of up to 26,809,600 shares, which shareholders should weigh against the added funding.
$1.0 billion principal of 3.00% convertible senior notes due August 1, 2028 sold in a private offering, including $100 million from the option exercise
Net proceeds of approximately $986.8 million after initial purchaser discounts and offering expenses
Initial conversion price of about $46.63 per share, a 25.0% premium to the July 28, 2025 NYSE closing price
Up to 26,809,600 shares of common stock may be issued on conversion; the company may pay cash up to principal
Virtu Financial said its Board appointed Chief Technology Officer Aaron Simons as Chief Executive Officer and a director, effective August 1, 2025, succeeding Douglas Cifu, who steps down as CEO and Board member and will remain as a consultant through December 31, 2025. The filing discloses severance and consulting payments to Cifu and Simons's employment terms, which bear on the cost and continuity of the leadership change for shareholders.
Aaron Simons, 45, joined Virtu in 2008 and has served as Chief Technology Officer since 2019; his base salary is $600,000 with a target bonus of $2,000,000.
Douglas Cifu's separation includes severance pay through February 28, 2028, 150,000 Shares, and a $5,000,000 consulting payment for services through December 31, 2025.
Simons's employment agreement runs through February 26, 2027, with a severance pay floor of one times base salary or base salary through the end of the term.
PJT Partners appointed Peter L.S. Currie as a director effective July 30, 2025, increasing the Board to eight members, and placed him on the Audit Committee. The Board determined he is independent under New York Stock Exchange rules. The change adds a director with prior audit committee and public company board experience, but the filing reports no financial results or compensation beyond standard non-employee director pay.
Currie appointed effective July 30, 2025; Board size rises to eight members
Designated a Class II director, standing for election at the 2026 Annual Meeting
Also appointed to the Audit Committee effective July 30, 2025
Receives standard non-employee director compensation described in the April 29, 2025 proxy statement
StoneX completed its acquisition of R.J. O'Brien (RJO) on July 31, 2025, paying aggregate consideration of $610,566,926 in cash, subject to post-closing adjustment, plus 3,085,554 shares of StoneX common stock. The cash was partly funded by $625,000,000 of 6.875% senior secured notes due 2032, which were issued in July and released from escrow at closing; the notes are now secured on a second priority basis by substantially all company and guarantor assets. Shareholders face a larger combined company with more debt secured by company assets and new shares issued, and the company says the deal is expected to be accretive to earnings.
Cash consideration of $610,566,926, subject to post-closing adjustment, plus 3,085,554 shares of common stock issued as merger consideration
$625,000,000 of 6.875% Senior Secured Notes due 2032, issued under a July 8, 2025 indenture, were released from escrow on closing to help fund the cash price and fees
Notes are secured on a second priority basis by liens on substantially all company and guarantor assets, subject to exceptions
Per the press release, RJO generated $766 million in revenue and approximately $170 million in EBITDA in calendar 2024; the company expects the deal to be accretive to earnings
On July 29, 2025, Sun Communities' Compensation Committee granted cash transaction bonuses totaling $3.2 million to three executives, including CEO Gary A. Shiffman, for their work on the Safe Harbor Marinas sale. The filing ties the bonuses to a sale that the company says closed its initial phase on April 30, 2025 for $5.25 billion, so shareholders can see the payouts as tied to that transaction.
Gary A. Shiffman, Chief Executive Officer, received a $1,500,000 cash transaction bonus.
Fernando Castro-Caratini, Chief Financial Officer, received a $700,000 cash transaction bonus.
Aaron Weiss, Executive Vice President of Corporate Strategy and Business Development, received a $1,000,000 cash transaction bonus.
The bonuses were granted July 29, 2025, for the Safe Harbor Marinas sale, which had an initial closing on April 30, 2025 for $5.25 billion.
GXO Logistics appointed Patrick J. Byrne and Michael Kneeland as independent directors, effective immediately after the board expanded from nine to ten seats, and Jason Papastavrou resigned from the board. The filing says a new CEO is set to take over next month, and the board describes the changes as a board refresh.
Byrne appointed July 29, 2025; board expanded from nine to ten directors
Kneeland appointed July 30, 2025, following Papastavrou's resignation effective July 30, 2025
Each non-employee director receives an $80,000 annual cash retainer and a $190,000 annual RSU grant
Chairman Brad Jacobs said a new CEO is set to take the helm next month
Equitable Holdings said its insurance subsidiaries closed a transaction with RGA Reinsurance Company to reinsure 75% of their in-force individual life insurance block, with an effective date of April 1, 2025. The company says the deal generates more than $2 billion of value and reduces exposure to future mortality volatility, while the subsidiaries continue to administer the reinsured contracts. Second-quarter results are due after the market closes on August 5, 2025.
Deal closed July 31, 2025 under a Master Transaction Agreement dated February 23, 2025, with RGA Reinsurance Company
Ceding companies reinsured a 75% quota share of their in-force individual life insurance blocks, with assets placed in trust accounts to secure obligations
AllianceBernstein agreed on June 16, 2025 to manage assets representing approximately 70% of reserves tied to the ceded policies
Equitable Holdings reports second-quarter results after the market closes on August 5, 2025, with an investor call on August 6, 2025
Five9 said CEO Michael Burkland will retire once a successor is appointed and begins serving as CEO, and he will then serve up to six months as Executive Chairman. Bryan Lee, the company's interim CFO since April 1, 2025, was named permanent Chief Financial Officer effective July 31, 2025, and the board also proposed declassifying the board and removing its supermajority vote threshold at the 2026 annual meeting.
Burkland remains CEO until a successor begins serving; a committee of independent directors has started a search for the next CEO
Burkland's transition pay: $70,000 annual salary as Executive Chairman during a Transition Period of up to 6 months after the CEO Transition Date
Lee's CFO package includes a $456,000 base salary, a 75% target bonus, a $3.0 million RSU award and a $1.5 million target PRSU award
Board intends to phase out its classified structure by the 2028 annual meeting and replace the 66 2/3% supermajority vote with a majority threshold effective after the 2027 Annual Meeting
Healthcare Realty Trust and its operating partnership entered a new credit agreement dated July 25, 2025, replacing the existing facility with a $1.5 billion unsecured revolver and five unsecured term loan tranches totaling $1.115 billion. The revolver's maturity was extended from October 31, 2025 to July 25, 2029, which pushes out near-term refinancing needs for shareholders.
Revolver maturity extended from October 31, 2025 to July 25, 2029, with two six-month extension options
Five term loan tranches totaling $1.115 billion, with maturities ranging from October 31, 2025 to January 20, 2028
Current revolver margin is 0.85% per annum over the applicable benchmark, with a range of 0.725% to 1.40% based on credit ratings
Wells Fargo Bank, National Association serves as administrative agent
Sabra's operating partnership entered into a $500.0 million unsecured term loan on July 30, 2025, with an accordion feature that can raise total available borrowings to $1.0 billion. On July 31, 2025, the partnership redeemed all $500.0 million of its 5.125% Senior Notes due 2026, so the new loan refinances that debt.
Term loan of $500.0 million matures July 30, 2030; the accordion can increase total available borrowings to $1.0 billion, subject to terms.
Interest is SOFR-based or Base Rate plus a ratings-based margin of 0.800% to 1.600% for SOFR borrowings and 0.000% to 0.600% for Base Rate borrowings.
Interest rate swaps with $500.0 million notional fix the SOFR portion at a weighted average 3.44%, for an effective Term Loan rate of 4.64% through July 30, 2030.
The 2026 Notes were redeemed at 100.575% of principal plus accrued and unpaid interest.
On July 31, 2025, Xencor appointed Raymond J. Deshaies, Ph.D., as a new member of its Board of Directors. He will receive an initial stock option grant with a Black Scholes value of $550,000 and a $50,000 annual cash retainer for board service.
Appointed to the board on July 31, 2025; he recently served as senior vice president of global research at Amgen Inc.
Initial option grant has a Black Scholes value of $550,000; one-third vests on the one-year anniversary, with the rest vesting in 24 monthly installments, fully vested at three years.
Receives a $50,000 annual cash retainer and is eligible for future equity compensation.
Acurx Pharmaceuticals filed a certificate of amendment to combine every twenty shares of its common stock into one share, effective 4:01 p.m. Eastern Time on August 4, 2025. The company says the split is intended to raise the per-share trading price so it can regain compliance with Nasdaq's minimum bid price requirement. Shareholders will receive cash in lieu of any fractional shares, and the number of authorized shares will not change.
Ratio is 1-for-20, with shares expected to trade on a split-adjusted basis on The Nasdaq Capital Market from August 5, 2025 under the symbol ACXP
Shares outstanding are expected to fall from about 30,764,540 as of July 24, 2025 to about 1,538,227 after the split
Stockholders approved the reverse split at the annual meeting held July 17, 2025
The stated purpose is to help the company regain compliance with Nasdaq's minimum bid price requirement
Boyd Gaming's subsidiary completed the sale of its 5% equity interest in FanDuel on July 31, 2025, receiving aggregate cash consideration of $1.758 billion. The company said it intends to use the proceeds to repay existing debt. The filing also describes new and terminated agreements, including a longer-term market access arrangement and a move of FanDuel-branded sportsbooks at Boyd properties to Boyd branding and operation.
Cash consideration received: $1.758 billion, stated in both the 8-K and the press release
Boyd intends to use the proceeds to repay existing debt
The 8-K names TSE Holdings Ltd. as the buyer; the press release names Flutter Entertainment plc (NYSE: FLUT)
FanDuel-branded sportsbooks at Boyd Gaming properties will be branded and operated entirely by Boyd entities, using certain FanDuel sports betting data feeds
Supernus Pharmaceuticals completed its acquisition of Sage Therapeutics after 36,313,509 Sage shares, about 58% of those outstanding, were tendered by the July 30, 2025 expiration of the offer. Sage is now a wholly owned subsidiary, and the Sage shares will be delisted from the Nasdaq Global Market. The total cash consideration excluding contingent value rights is approximately $561 million, and the CVRs add up to $3.50 per share in potential future payments tied to milestones that may never be reached.
Offer price was $8.50 per Sage share in cash plus one contingent value right worth up to $3.50 per share
Aggregate consideration is approximately $561 million, excluding amounts that may be payable under the CVRs
Maximum total CVR payments are approximately $234 million, with milestones tied to ZURZUVAE net sales and a Japan approval by June 30, 2026
The merger closed on July 31, 2025 without a Sage stockholder vote, and the Sage shares will be delisted from the Nasdaq Global Market
Euronet Worldwide agreed on July 30, 2025 to acquire CoreCard Corporation in a stock-for-stock merger that values CoreCard at approximately $248 million, or $30 per share. CoreCard shareholders would receive Euronet shares under an exchange ratio that moves between 0.2783 and 0.3142 depending on Euronet's stock price, and the deal requires CoreCard shareholder approval and regulatory clearance, with closing expected in late 2025.
Merger consideration is $30 per CoreCard share, paid in Euronet common stock using an exchange ratio of 0.2783 to 0.3142.
Exchange ratio is fixed at 0.3142 if Euronet's stock price is at or below $95.48 and 0.2783 if it is at or above $107.80.
CoreCard would pay Euronet a $7.5 million termination fee under specified circumstances.
Outside Date is January 30, 2026, subject to two automatic three-month extensions in certain cases.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.